united scientific group presents virtual series of cancer ... · title: cancer evolution under...
TRANSCRIPT
Immunotherapy in Cancer
October, 26, 2020
Jason D. Marshall, Leidos Biomedical Research, Inc., NCI Campus at Frederick, MD
Title: Performance Optimization of a Novel HPV VLP Vaccine in Mice with Novel Adjuvants
Joseph Markowitz, Moffit Cancer Center, FL
Title: Duality of NO in Melanoma
Yan Leyfman, Penn State College of Medicine, PA
Title: Finetune Your CARs: Building the Next Generation of Anti-Cancer Therapies
Shannon Lauberth, University of California at San Diego, CA, USA
Title: Title to be updated
Joost J. Oppenheim, NIH/NCI, MD, USA
Title: Oncolytic Reagents may also Enhance Anti-Tumor Immunity by Inducing MyD88-dependent Maturation of Dendritic Cells
Wayne Godfrey, Vice President of Clinical Development at IGM Bioscience
Title: A Novel Approach to Engineering Antibody Based Immunotherapy
Jerry W. Shay, UT Southwestern Medical Center, Dallas, Texas
Title: Telomere Stress Potentiates STING-Dependent Anti-Tumor Immunity
Guido Kroemer, Gustave Roussy Comprehensive Cancer Center, INSERM, France
Title: Overcoming a Frequent Inborn Immune Defect in Breast Cancer Therapy
William Hearl, Ph.D. CEO, Immunomic Therapeutics, MD
Title: To be Updated
Brian Francica, Tempest Therapeutics, CA
Title: Dual Antagonism of Prostaglandin Receptors EP2 and EP4 by TPST-1495 Suppresses Tumor Growth and Stimulates Antitumor Immunity
Eduardo Davila, University of Colorado CU Comprehensive Cancer Center, CO
Title: Novel Gene Platforms to Maintain the Persistence and Antitumor Activity of TIL-, CAR-, and DC-Based Therapies
Pooja Jain, Drexel University College of Medicine, Philadelphia, PA
Title: The MAPK/ERK-regulated MEF-2 isoforms as potential new target(s) for HTLV-1 induced Adult T-cell leukemia/lymphoma (ATLL)
Jing H. Wang, University of Colorado Anschutz Medical Campus, CO
Title: MHC Class-I Independent Activation of Virtual-Memory CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells
Tel: +1 469-854-2280/81Email: [email protected]; [email protected]
Twitter: @KK_usgcancer
United Scientific Group
A non-profit organization
United Scientific Group Presents
Virtual Series of Cancer R&D & ICHEM-2020
Session Speakers
Scott K. Durum, NCI/CCR, NIH, MD, USA
Title: Title to be updated
Lauren V. Wood, Chief Medical Officer, PDS Biotechnology, NJ
Title: Versamune (R-D0TAP): a Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens